Discover what really happens when you die — the brain's final surge, chemical releases, and the mysterious experiences at the ...

Altimmune is developing pemvidutide for obesity and liver diseases, with recent MOMENTUM sub-study results showing favorable ...

In the field of myelodysplastic syndromes (MDS), there are a number of investigational studies designed with the hope of ...

Unsupervised use of hallucinogens like LSD is high, posing significant risks. However, LSD is being clinically tested for treating anxiety and so far seems effective.

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

US clinical-stage firm ESSA Pharma has made the decision to terminate the Phase II clinical trial evaluating in a 2:1 ...

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

A recent phase 3 clinical trial led by an international research team showed ... curbing swelling and tissue damage, which ...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) recently disclosed significant clinical data from its Phase 1 expansion dose of IDE397 in patients with MTAP-deletion urothelial cancer and non-small cell lung ...

Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, today announced the closing of an oversubscribed $62M Series C funding ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented participant baseline ...

(Alliance News) - Ondine Biomedical Inc on Friday revealed a proposed fundraise as it looks to fund a phase 3 clinical study in the US. Ondine Biomedical is a Vancouver, Canada-based life sciences ...